Dyne Therapeutics, Inc.
DYN
$20.09
$0.100.50%
NASDAQ
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 0.71% | 3.96% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -1.64% | -5.38% | |||
| Operating Income | 1.64% | 5.38% | |||
| Income Before Tax | 2.54% | 3.90% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 2.54% | 3.90% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 2.54% | 3.90% | |||
| EBIT | 1.64% | 5.38% | |||
| EBITDA | 1.66% | 5.40% | |||
| EPS Basic | 21.74% | 7.25% | |||
| Normalized Basic EPS | 21.73% | 7.26% | |||
| EPS Diluted | 21.74% | 7.25% | |||
| Normalized Diluted EPS | 21.73% | 7.26% | |||
| Average Basic Shares Outstanding | 24.53% | 3.60% | |||
| Average Diluted Shares Outstanding | 24.53% | 3.60% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||